RxDoctor Payments DataLook up a doctor →

Charles Huh, MD

Gastroenterology · Huntington, WVNPI 1346288941

Payments from drug & device makers

$6,784in general payments, 2019–2025

Across 450 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$747
  • Novo Nordisk$621
  • Takeda Pharmaceuticals U.S.A., Inc.$381
  • Johnson & Johnson$260
  • QOL Medical, LLC$240
  • plus $3K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)81$1,099
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC62$747
Novo Nordisk43$621
Takeda Pharmaceuticals U.S.A., Inc.25$381
Johnson & Johnson(2 entities)22$260
QOL Medical, LLC10$240
Lilly USA, LLC12$229
Amgen15$218
Gilead12$192
Bayer10$177
AstraZeneca(2 entities)11$168
Boehringer Ingelheim12$163
Argenx US, Inc.8$154
Bristol Myers Squibb10$151
Esperion Therapeutics, Inc.10$145
Redhill Biopharma Inc.9$132
Ipsen Biopharmaceuticals, Inc5$129
Paratek Pharmaceuticals, Inc.6$113
Nestle Healthcare Nutrition Inc.4$102
Pfizer6$99
Ferring Pharmaceuticals Inc.5$78
Biohaven Pharmaceutical Holding Company Ltd.4$71
Ironwood Pharmaceuticals, Inc4$67
Shionogi Inc4$65
Otsuka America Pharmaceutical, Inc.4$65
Avanir Pharmaceuticals, Inc.4$59
Celltrion USA Inc.3$53
Vifor Pharma, Inc.4$50
Intercept Pharmaceuticals, Inc.3$47
E.r. Squibb & Sons, L.L.C.3$47
Ardelyx, Inc.3$45
Phathom Pharmaceuticals, Inc.3$41
Biohaven Pharmaceuticals, Inc.3$38
Teva Pharmaceuticals USA, Inc.2$37
Merck2$33
Smith+Nephew2$33
Shield Therapeutics Inc2$29
Evoke Pharma, Inc.2$29
Aurinia Pharma U.S., Inc.1$28
Amarin Pharma, Inc.2$26
Abbott1$25
Sanofi1$24
Philips North America LLC1$23
Aimmune Therapeutics, Inc.1$22
Xeris Pharmaceuticals, Inc.1$22
Biogen1$22
Baxter Healthcare1$21
UCB, Inc.1$20
Braintree Laboratories, Inc.1$18
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$18
Exact Sciences1$18
Kowa Pharmaceuticals America, Inc.1$17
Pharmacosmos Therapeutics Inc.1$17
Boston Scientific1$14
Eisai Inc.1$14
Regeneron Healthcare Solutions, Inc.1$14
Endo Pharmaceuticals Inc.1$12

How this compares

$6,784 in reported general payments places this provider in the 70th percentile of 72 gastroenterology providers in West Virginia.

See all gastroenterology providers in West Virginia

Medicare billing

Part B allowed, 2024
$85,733
Medicare patients
371
Services billed
834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →